Top compounds associated with response to TRIO


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.027 0.6
mRNA tivozanib GDSC1000 pan-cancer AAC -0.037 0.3
mRNA tivozanib CTRPv2 pan-cancer AAC -0.031 0.4
mRNA tosedostat CTRPv2 pan-cancer AAC -0.063 0.1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0033 0.9
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.0069 0.8
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.081 0.06
mRNA triptolide CTRPv2 pan-cancer AAC -0.057 0.1
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.079 0.02
Download CSV